The contemporary management of cancers of the sinonasal tract in adults
Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …
SWI/SNF chromatin remodeling and human malignancies
J Masliah-Planchon, I Bièche… - Annual Review of …, 2015 - annualreviews.org
The SWI/SNF complexes, initially identified in yeast 20 years ago, are a family of multi-
subunit complexes that use the energy of adenosine triphosphate (ATP) hydrolysis to …
subunit complexes that use the energy of adenosine triphosphate (ATP) hydrolysis to …
SMARCB1 (INI-1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity
A Agaimy, A Hartmann, CR Antonescu… - The American journal …, 2017 - journals.lww.com
To more fully characterize the clinical and pathologic spectrum of a recently described tumor
entity of the sinonasal tract characterized by loss of nuclear expression of SMARCB1 (INI1) …
entity of the sinonasal tract characterized by loss of nuclear expression of SMARCB1 (INI1) …
Update from the 5th Edition of the World Health Organization classification of head and neck tumors: nasal cavity, paranasal sinuses and skull base
LDR Thompson, JA Bishop - Head and Neck Pathology, 2022 - Springer
Abstract The World Health Organization Classification of Head and Neck Tumours recently
published the 5th edition. There are new entities, emerging entities, and significant updates …
published the 5th edition. There are new entities, emerging entities, and significant updates …
Oncogenic roles of SMARCB 1/INI 1 and its deficient tumors
K Kohashi, Y Oda - Cancer science, 2017 - Wiley Online Library
SMARCB 1/INI 1 is one of the core subunit proteins of the ATP‐dependent SWI/SNF
chromatin remodeling complex, and is identified as a potent and bona fide tumor …
chromatin remodeling complex, and is identified as a potent and bona fide tumor …
SMARCA4-deficient sinonasal carcinoma: a series of 10 cases expanding the genetic spectrum of SWI/SNF-driven sinonasal malignancies
The molecular pathogenesis of poorly differentiated sinonasal carcinoma received
significant attention in recent years. As a consequence, several unclassified carcinomas in …
significant attention in recent years. As a consequence, several unclassified carcinomas in …
Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities
RS Pierre, C Kadoch - Current opinion in genetics & development, 2017 - Elsevier
Mammalian SWI/SNF (BAF) chromatin remodeling complexes orchestrate a diverse set of
chromatin alterations which impact transcriptional output. Recent whole-exome sequencing …
chromatin alterations which impact transcriptional output. Recent whole-exome sequencing …
SMARCA4 and SMARCA2 deficiency in non–small cell lung cancer: immunohistochemical survey of 316 consecutive specimens
E Herpel, RJ Rieker, H Dienemann, T Muley… - Annals of diagnostic …, 2017 - Elsevier
The chromatin remodeling switch sucrose nonfermentable (SWI/SNF) complex has been
increasingly implicated in the pathogenesis and dedifferentiation of neoplasms from several …
increasingly implicated in the pathogenesis and dedifferentiation of neoplasms from several …
New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base
LDR Thompson, A Franchi - Virchows Archiv, 2018 - Springer
Abstract The World Health Organization recently published the 4th edition of the
Classification of Head and Neck Tumors, including several new entities, emerging entities …
Classification of Head and Neck Tumors, including several new entities, emerging entities …
[HTML][HTML] DNA methylation-based classification of sinonasal undifferentiated carcinoma
S Dogan, V Vasudevaraja, B Xu, J Serrano… - Modern Pathology, 2019 - Elsevier
Sinonasal undifferentiated carcinoma (SNUC) is an aggressive malignancy harboring IDH2
R172 mutations in> 80% cases. We explored the potential of genome-wide DNA methylation …
R172 mutations in> 80% cases. We explored the potential of genome-wide DNA methylation …